Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2

In December 2019, an outbreak of viral pneumonia caused by a novel coronavirus (since named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease – now known as coronavirus di...

[1]  Feng Li,et al.  Risk assessment of venous thromboembolism and bleeding in COVID-19 patients , 2020 .

[2]  H. Anders,et al.  Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  P. Pelosi,et al.  Emerging therapies for COVID-19 pneumonia , 2020, Expert opinion on investigational drugs.

[4]  J. Thachil,et al.  Coagulation abnormalities and thrombosis in patients with COVID-19 , 2020, The Lancet Haematology.

[5]  P. Pelosi,et al.  Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 , 2020, Respiratory Physiology & Neurobiology.

[6]  F. Carod-Artal.  Complicaciones neurológicas por coronavirus y COVID-19./ Complicaciones neurológicas por coronavirus y COVID-19./ Neurological complications of coronavirus and COVID-19. , 2020 .

[7]  F. J. Carod-Artal.  Neurological complications of coronavirus and COVID-19. , 2020, Revista de neurologia.

[8]  F. J. Carod-Artal,et al.  Neurological complications of coronavirus and COVID-19. , 2020, Revista de neurologia.

[9]  Mark M. Davis,et al.  Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response , 2020, Current Cardiology Reports.

[10]  H. Cate.  Thrombosis management in times of COVID-19 epidemy; a Dutch perspective , 2020 .

[11]  H. ten Cate.  Thrombosis management in times of COVID-19 epidemy; a Dutch perspective , 2020, Thrombosis Journal.

[12]  M. Woodward,et al.  The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis , 2020, Progress in Cardiovascular Diseases.

[13]  G. Manley,et al.  Smell and taste dysfunction in patients with COVID-19 , 2020, The Lancet Infectious Diseases.

[14]  L. Camporota,et al.  COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.

[15]  A. Zangrillo,et al.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis , 2020, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[16]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[17]  Giuseppe Citerio,et al.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.

[18]  Erika Poggiali,et al.  Abdominal Pain: A Real Challenge in Novel COVID-19 Infection , 2020, European journal of case reports in internal medicine.

[19]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[20]  H. Tilg,et al.  Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel , 2020, The Lancet Gastroenterology & Hepatology.

[21]  Dongyin Zhang,et al.  Prognostic value of NT-proBNP in patients with severe COVID-19 , 2020, Respiratory Research.

[22]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[23]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[24]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[25]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[26]  SEPSIS BULLETIN,et al.  Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease , 2020 .

[27]  Yunhui Zeng,et al.  Elevated level of D-dimer increases the risk of stroke , 2017, Oncotarget.

[28]  David K. Meyerholz,et al.  Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.

[29]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.